These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 29807728)
1. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728 [TBL] [Abstract][Full Text] [Related]
2. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488 [TBL] [Abstract][Full Text] [Related]
3. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. Pointer DT; Roife D; Powers BD; Murimwa G; Elessawy S; Thompson ZJ; Schell MJ; Hodul PJ; Pimiento JM; Fleming JB; Malafa MP BMC Cancer; 2020 Aug; 20(1):750. PubMed ID: 32782024 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study. Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil-Lymphocyte Ratio as a Prognostic Marker for Lung Adenocarcinoma After Complete Resection. Takahashi Y; Kawamura M; Hato T; Harada M; Matsutani N; Horio H World J Surg; 2016 Feb; 40(2):365-72. PubMed ID: 26493696 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors. Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S Med Sci Monit; 2017 Nov; 23():5574-5588. PubMed ID: 29168979 [TBL] [Abstract][Full Text] [Related]
7. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma. Abe T; Nakata K; Kibe S; Mori Y; Miyasaka Y; Ohuchida K; Ohtsuka T; Oda Y; Nakamura M Ann Surg Oncol; 2018 Dec; 25(13):3996-4003. PubMed ID: 30225838 [TBL] [Abstract][Full Text] [Related]
9. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma. Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
11. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer]. Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC). Xiang ZJ; Hu T; Wang Y; Wang H; Xu L; Cui N Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510138 [TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma. Fang LP; Xu XY; Ji Y; Huang PW World J Surg; 2018 Nov; 42(11):3736-3745. PubMed ID: 30014292 [TBL] [Abstract][Full Text] [Related]
14. Impact of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios on Long-Term Survival in Patients with Operable Pancreatic Ductal Adenocarcinoma. Romano L; Giuliani A; Tomarelli C; Nervini A; Lazzarin G; Pessia B; Vicentini V; Carlei F; Schietroma M Med Princ Pract; 2022; 31(6):586-594. PubMed ID: 36323225 [TBL] [Abstract][Full Text] [Related]
15. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma. Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703 [TBL] [Abstract][Full Text] [Related]
16. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer. Chawla A; Huang TL; Ibrahim AM; Hardacre JM; Siegel C; Ammori JB HPB (Oxford); 2018 May; 20(5):398-404. PubMed ID: 29221789 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma. Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641 [TBL] [Abstract][Full Text] [Related]
18. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer. Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206 [TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. Garcea G; Ladwa N; Neal CP; Metcalfe MS; Dennison AR; Berry DP World J Surg; 2011 Apr; 35(4):868-72. PubMed ID: 21312035 [TBL] [Abstract][Full Text] [Related]
20. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection. Kim NH; Kim HJ Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]